Ferritin Increase in Hemochromatosis Subjects After Discontinuing Their Regular Maintenance Treatment: A Longitudinal Analysis Performed During the COVID-19 Imposed Hospital Lockdown.
作者信息
Coutinho Maria P, Teles Maria José, Melo Graça, Lopes Marta, Duarte Delfim, Duarte Tiago L, Reis Júlia, Martins Ana Cláudia, Oliveira José Carlos, Porto Graça
机构信息
Clinical Hematology, CHUP-Centro Hospitalar Universitário do Porto, Portugal.
Basic & Clinical Research on Iron Biology, i3S- Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Portugal.
出版信息
Hemasphere. 2022 Aug 23;6(9):e770. doi: 10.1097/HS9.0000000000000770. eCollection 2022 Sep.
Abstract
摘要
相似文献
1
Ferritin Increase in Hemochromatosis Subjects After Discontinuing Their Regular Maintenance Treatment: A Longitudinal Analysis Performed During the COVID-19 Imposed Hospital Lockdown.
Hemasphere. 2022 Aug 23;6(9):e770. doi: 10.1097/HS9.0000000000000770. eCollection 2022 Sep.
2
Worse Outcomes of Patients With HFE Hemochromatosis With Persistent Increases in Transferrin Saturation During Maintenance Therapy.
Clin Gastroenterol Hepatol. 2017 Oct;15(10):1620-1627. doi: 10.1016/j.cgh.2016.12.039. Epub 2017 Jan 20.
3
Evolution of untreated hereditary hemochromatosis in the Busselton population: a 17-year study.
Mayo Clin Proc. 2004 Mar;79(3):309-13. doi: 10.4065/79.3.309.
4
Immunohistochemical evidence for a lack of ferritin in duodenal absorptive epithelial cells in idiopathic hemochromatosis.
Gastroenterology. 1989 Apr;96(4):1071-8. doi: 10.1016/0016-5085(89)91625-9.
5
Multiplying effects of COVID-19 lockdown on metabolic risk and fatty liver.
Eur J Clin Invest. 2021 Jul;51(7):e13597. doi: 10.1111/eci.13597. Epub 2021 May 25.
6
Diagnosis of hemochromatosis in young subjects: predictive accuracy of biochemical screening tests.
Gastroenterology. 1984 Sep;87(3):628-33.
7
Ferritin synthesis in peripheral blood monocytes in idiopathic hemochromatosis.
J Lab Clin Med. 1982 Jul;100(1):137-45.
8
Usefulness of erythrocyte ferritin analysis in hereditary hemochromatosis.
CMAJ. 1987 Jun 15;136(12):1259-64.
9
Biliary excretion of iron and ferritin in idiopathic hemochromatosis.
Gastroenterology. 1989 Jun;96(6):1539-45. doi: 10.1016/0016-5085(89)90524-6.
10
Monocyte membrane ferritin in hemochromatosis.
Clin Invest Med. 1991 Oct;14(5):402-8.
本文引用的文献
1
Hemochromatosis classification: update and recommendations by the BIOIRON Society.
Blood. 2022 May 19;139(20):3018-3029. doi: 10.1182/blood.2021011338.
2
Reduced phenotypic expression in genetic hemochromatosis with time: Role of exposure to non-genetic modifiers.
J Hepatol. 2019 Jan;70(1):118-125. doi: 10.1016/j.jhep.2018.09.009. Epub 2018 Sep 21.
3
Therapeutic recommendations in HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) homozygous genotype.
Hepatol Int. 2018 Mar;12(2):83-86. doi: 10.1007/s12072-018-9855-0. Epub 2018 Mar 27.
4
EMQN best practice guidelines for the molecular genetic diagnosis of hereditary hemochromatosis (HH).
Eur J Hum Genet. 2016 Apr;24(4):479-95. doi: 10.1038/ejhg.2015.128. Epub 2015 Jul 8.
5
Evidence for distinct pathways of hepcidin regulation by acute and chronic iron loading in mice.
Hepatology. 2011 Apr;53(4):1333-41. doi: 10.1002/hep.24178.
6
Enhanced erythropoiesis in Hfe-KO mice indicates a role for Hfe in the modulation of erythroid iron homeostasis.
Blood. 2011 Jan 27;117(4):1379-89. doi: 10.1182/blood-2010-09-307462. Epub 2010 Nov 8.
7
EASL clinical practice guidelines for HFE hemochromatosis.
J Hepatol. 2010 Jul;53(1):3-22. doi: 10.1016/j.jhep.2010.03.001. Epub 2010 Apr 18.
8
Kidney and anemia in familial amyloidosis type I.
Kidney Int. 2004 Nov;66(5):2004-9. doi: 10.1111/j.1523-1755.2004.00971.x.
9
Long-term survival in patients with hereditary hemochromatosis.
Gastroenterology. 1996 Apr;110(4):1107-19. doi: 10.1053/gast.1996.v110.pm8613000.
10
Rate of iron reaccumulation following iron depletion in hereditary hemochromatosis. Implications for venesection therapy.
J Clin Gastroenterol. 1993 Apr;16(3):207-10. doi: 10.1097/00004836-199304000-00008.
Zotero 插件